サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1335915

ペニシリン製剤の世界市場規模、シェア、産業動向分析レポート：供給源別、活性領域別、流通経路別、投与経路別、地域別展望と予測、2023年～2030年

Global Penicillin Drug Market Size, Share & Industry Trends Analysis Report By Source, By Spectrum of Activity, By Distribution Channel, By Route of Administration, By Regional Outlook and Forecast, 2023 - 2030
出版日: | 発行: KBV Research | ページ情報: 英文 284 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ペニシリン製剤の世界市場規模、シェア、産業動向分析レポート：供給源別、活性領域別、流通経路別、投与経路別、地域別展望と予測、2023年～2030年
出版日: 2023年07月31日
発行: KBV Research
ページ情報: 英文 284 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ペニシリン製剤市場規模は2030年までに109億米ドルに達し、予測期間中にCAGR 3.6%の市場成長率で上昇すると予測されます。

KBV Cardinalのマトリックスに掲載された分析によると、ファイザー社が同市場におけるトップランナーです。2022年1月、Pfizer, Inc.はBecton, Dickinson, and Companyと提携し、抗菌薬を正しく使用するためのソリューションを開発しました。グラクソ・スミスクラインPLC（GSK）、ノバルティスAG、アボット・ラボラトリーズなどの企業は、この市場における主要なイノベーターです。

市場成長要因

細菌性疾患の発生率の増加

細菌によって引き起こされる病気は、人々の健康に大きな影響を与えます。誰でもこの病気にかかる可能性があり、その病気は細菌自体によって、あるいは細菌の存在に対する身体の反応によって引き起こされます。人間は、食物、水、空気、生物などを介して細菌に感染する可能性があります。この薬は、細菌が細胞壁を形成するのを助ける酵素を破壊します。異なる感染症には、異なるタイプのペニシリンが利用されます。アモキシシリン、アンピシリン、オーグメンチン、ペニシリンG、ペニシリンVはペニシリンの数種類です。上記の要素を考慮すると、拡大する細菌感染が市場の拡大を後押しすると予測されます。

効率的で最新の抗生物質に対する需要の増加

新しい抗生物質を開発し市場に投入するのは難しい仕事です。それでも、薬剤耐性疾患の脅威の高まりから人々を守るためには、それを達成しなければならないです。最初の抗生物質であるペニシリンが発見されて以来、現代医学は革命を遂げました。細菌は最終的に新しい薬に対する耐性を獲得します。また、スーパーバグとの終わりのない戦いに先んじるためには、診断法、ワクチン接種、より優れた予防、管理、モニタリングの開発が必要です。WHOによると、40～50種類の抗生物質が臨床開発段階にあります。その結果、抗生物質に対する需要の増加により、この市場は今後数年間で成長すると思われます。

市場抑制要因

多剤耐性（MDR）感染症の増加

ヘルスケアシステムに影響を及ぼしている最大の問題のひとつが、公衆衛生に重大なリスクをもたらす抗生物質耐性です。これらの菌株は、当初はホスピタリティのある病院内に限られていたが、現在では広く蔓延しています。抗生物質耐性の蔓延の原因として特定されているのは、世界化、水産養殖、複数の広域スペクトル薬の使用、畜産における抗生物質の過剰使用、適切な抗菌薬スチュワードシップの欠如などです。抗生物質耐性菌の増加を考えると、病気の治療に使用できる抗菌薬の数は少なくならざるを得ないです。

供給源の展望

供給源に基づいて、市場は天然ペニシリンと半合成ペニシリンに区分されます。天然ペニシリンは、2022年に市場でかなりの収益シェアを獲得しました。天然ペニシリンは、ボレリア、連鎖球菌、髄膜炎菌、ブドウ球菌、トレポネーマ、レプトスピラを含むグラム陽性菌とグラム陰性菌の両方に対して効率的です。ペニシリンVは経口用のみで、ペニシリンGは非経口用です。バクテロイデス・フラジリスを除き、これらの薬剤は嫌気性菌を含むグラム陽性菌が引き起こす疾患の診断に最もよく使用されます。

活性スペクトルの展望

活性スペクトルによって、市場はナロースペクトル、ブロードスペクトル、エクステンデッドスペクトルに分類されます。2022年には、広域スペクトルが市場で最大の売上シェアを占める。咽頭、耳、鼻副鼻腔、呼吸器（肺炎など）、尿路、皮膚・軟部組織、腸チフスなどの感染症はすべて、ペニシリンに関連する抗生物質の一種である広域スペクトルペニシリン系抗菌薬で治療できます。アンピシリンとそのエステル（バカピシリン、ピバンピシリン、タランピシリンなど）、アモキシシリン、コアモキシクラフ、メズロシリンなどが主な広域ペニシリン系抗生物質です。

流通チャネルの展望

流通チャネル別に見ると、市場は病院、ドラッグストア・小売薬局、オンラインプロバイダーに細分化されます。2022年の市場では、オンラインプロバイダー分野が突出した売上シェアを予測しています。ペニシリン製剤は複数のオンラインベンダーで販売されており、消費者はそれぞれのニーズに合ったブランド、用量、製剤を見つけることができます。さらに、24時間365日利用可能なプラットフォームのため、ユーザーはいつでもオンラインで買い物ができます。これらの要因がこのセグメントの成長を牽引していくと思われます。

投与経路の展望

投与経路に基づき、市場は経口剤と非経口剤に分類されます。2022年には、非経口投与セグメントが市場で最も高い売上シェアを占めました。重篤な細菌感染症の治療におけるペニシリン注射の使用増加や、ペニシリンG注射が主な治療法である梅毒の有病率の上昇による。心停止やアナフィラキシーショックの緊急時など、他のドラッグデリバリー方法よりも非経口投与が好まれる場合もあります。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAに分析されます。2022年には、アジア太平洋地域が最も高い収益シェアを獲得して市場をリードしました。この成長は、同地域の感染症罹患率の上昇とペニシリン製剤の需要増に関連しています。中国やインドのような国々の人口増加に伴い、アジア太平洋地域はペニシリン薬を含む抗生物質の最大市場の一つとなっています。さらに、アジア太平洋市場は、ヘルスケアコストの上昇、ヘルスケアインフラの改善、抗生物質の使用知識の増加、同地域における大手製薬会社の存在などの要因により、大きく拡大しています。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場の概要

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因

第4章 競合分析- 世界

  • KBVカーディナルマトリックス
  • 最近の業界全体の戦略的展開
    • パートナーシップ、コラボレーション、および契約
    • 製品の発売と製品の拡大
    • 買収と合併
    • 試験と承認
  • 主要成功戦略
    • 主な戦略
    • 主要な戦略的動き
  • ポーターファイブフォース分析

第5章 世界のペニシリン医薬品市場：ソース別

  • 世界の半合成ペニシリン市場：地域別
  • 世界の天然ペニシリン市場：地域別

第6章 世界のペニシリン医薬品市場：活動範囲別

  • 世界のブロードスペクトラム市場：地域別
  • 世界の拡張スペクトル市場：地域別
  • 世界の狭帯域市場：地域別

第7章 世界のペニシリン医薬品市場：流通チャネル別

  • 世界のドラッグストアおよび小売薬局市場：地域別
  • 世界の病院薬局市場：地域別
  • 世界のオンラインプロバイダー市場：地域別

第8章 世界のペニシリン医薬品市場：投与経路別

  • 世界の非経口薬市場：地域別
  • 世界の口腔市場：地域別

第9章 世界のペニシリン医薬品市場：地域別

  • 北米
    • 北米の市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第10章 企業プロファイル

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • GlaxoSmithKline PLC（GSK）
  • Pfizer, Inc
  • Lupin Limited
  • Abbott Laboratories
  • Cipla Limited
  • Alkem Laboratories Ltd
  • Takeda Pharmaceutical Company Limited

第11章 ペニシリン医薬品市場の勝利の必須条件

図表

LIST OF TABLES

  • TABLE 1 Global Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 2 Global Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Penicillin Drug Market
  • TABLE 4 Product Launches And Product Expansions- Penicillin Drug Market
  • TABLE 5 Acquisition and Mergers- Penicillin Drug Market
  • TABLE 6 Trials and Approvals- Penicillin Drug Market
  • TABLE 7 Global Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 8 Global Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 9 Global Semisynthetic Penicillin Market by Region, 2019 - 2022, USD Million
  • TABLE 10 Global Semisynthetic Penicillin Market by Region, 2023 - 2030, USD Million
  • TABLE 11 Global Natural Penicillin Market by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Natural Penicillin Market by Region, 2023 - 2030, USD Million
  • TABLE 13 Global Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 14 Global Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 15 Global Broad spectrum Market by Region, 2019 - 2022, USD Million
  • TABLE 16 Global Broad spectrum Market by Region, 2023 - 2030, USD Million
  • TABLE 17 Global Extended spectrum Market by Region, 2019 - 2022, USD Million
  • TABLE 18 Global Extended spectrum Market by Region, 2023 - 2030, USD Million
  • TABLE 19 Global Narrow spectrum Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Narrow spectrum Market by Region, 2023 - 2030, USD Million
  • TABLE 21 Global Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 22 Global Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 23 Global Drug Stores & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Drug Stores & Retail Pharmacies Market by Region, 2023 - 2030, USD Million
  • TABLE 25 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 26 Global Hospital Pharmacies Market by Region, 2023 - 2030, USD Million
  • TABLE 27 Global Online Providers Market by Region, 2019 - 2022, USD Million
  • TABLE 28 Global Online Providers Market by Region, 2023 - 2030, USD Million
  • TABLE 29 Global Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 30 Global Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 31 Global Parenteral Market by Region, 2019 - 2022, USD Million
  • TABLE 32 Global Parenteral Market by Region, 2023 - 2030, USD Million
  • TABLE 33 Global Oral Market by Region, 2019 - 2022, USD Million
  • TABLE 34 Global Oral Market by Region, 2023 - 2030, USD Million
  • TABLE 35 Global Penicillin Drug Market by Region, 2019 - 2022, USD Million
  • TABLE 36 Global Penicillin Drug Market by Region, 2023 - 2030, USD Million
  • TABLE 37 North America Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 38 North America Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 39 North America Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 40 North America Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 41 North America Semisynthetic Penicillin Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Semisynthetic Penicillin Market by Country, 2023 - 2030, USD Million
  • TABLE 43 North America Natural Penicillin Market by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Natural Penicillin Market by Country, 2023 - 2030, USD Million
  • TABLE 45 North America Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 46 North America Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 47 North America Broad spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Broad spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 49 North America Extended spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 50 North America Extended spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 51 North America Narrow spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 52 North America Narrow spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 53 North America Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 54 North America Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 55 North America Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 56 North America Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 57 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 58 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 59 North America Online Providers Market by Country, 2019 - 2022, USD Million
  • TABLE 60 North America Online Providers Market by Country, 2023 - 2030, USD Million
  • TABLE 61 North America Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 62 North America Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 63 North America Parenteral Market by Country, 2019 - 2022, USD Million
  • TABLE 64 North America Parenteral Market by Country, 2023 - 2030, USD Million
  • TABLE 65 North America Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 66 North America Oral Market by Country, 2023 - 2030, USD Million
  • TABLE 67 North America Penicillin Drug Market by Country, 2019 - 2022, USD Million
  • TABLE 68 North America Penicillin Drug Market by Country, 2023 - 2030, USD Million
  • TABLE 69 US Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 70 US Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 71 US Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 72 US Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 73 US Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 74 US Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 75 US Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 76 US Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 77 US Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 78 US Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 79 Canada Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 80 Canada Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 81 Canada Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 82 Canada Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 83 Canada Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 84 Canada Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 85 Canada Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 86 Canada Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 87 Canada Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 88 Canada Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 89 Mexico Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 90 Mexico Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 91 Mexico Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 92 Mexico Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 93 Mexico Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 94 Mexico Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 95 Mexico Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 96 Mexico Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 97 Mexico Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 98 Mexico Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 99 Rest of North America Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 100 Rest of North America Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 101 Rest of North America Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 102 Rest of North America Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 103 Rest of North America Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 104 Rest of North America Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 105 Rest of North America Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 106 Rest of North America Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 107 Rest of North America Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 108 Rest of North America Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 109 Europe Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 110 Europe Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 111 Europe Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 112 Europe Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 113 Europe Semisynthetic Penicillin Market by Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Semisynthetic Penicillin Market by Country, 2023 - 2030, USD Million
  • TABLE 115 Europe Natural Penicillin Market by Country, 2019 - 2022, USD Million
  • TABLE 116 Europe Natural Penicillin Market by Country, 2023 - 2030, USD Million
  • TABLE 117 Europe Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 118 Europe Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 119 Europe Broad spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Broad spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 121 Europe Extended spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 122 Europe Extended spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 123 Europe Narrow spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 124 Europe Narrow spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 125 Europe Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 126 Europe Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 127 Europe Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 128 Europe Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 129 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 130 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 131 Europe Online Providers Market by Country, 2019 - 2022, USD Million
  • TABLE 132 Europe Online Providers Market by Country, 2023 - 2030, USD Million
  • TABLE 133 Europe Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 134 Europe Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 135 Europe Parenteral Market by Country, 2019 - 2022, USD Million
  • TABLE 136 Europe Parenteral Market by Country, 2023 - 2030, USD Million
  • TABLE 137 Europe Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 138 Europe Oral Market by Country, 2023 - 2030, USD Million
  • TABLE 139 Europe Penicillin Drug Market by Country, 2019 - 2022, USD Million
  • TABLE 140 Europe Penicillin Drug Market by Country, 2023 - 2030, USD Million
  • TABLE 141 Germany Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 142 Germany Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 143 Germany Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 144 Germany Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 145 Germany Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 146 Germany Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 147 Germany Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 148 Germany Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 149 Germany Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 150 Germany Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 151 UK Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 152 UK Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 153 UK Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 154 UK Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 155 UK Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 156 UK Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 157 UK Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 158 UK Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 159 UK Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 160 UK Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 161 France Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 162 France Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 163 France Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 164 France Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 165 France Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 166 France Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 167 France Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 168 France Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 169 France Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 170 France Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 171 Russia Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 172 Russia Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 173 Russia Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 174 Russia Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 175 Russia Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 176 Russia Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 177 Russia Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 178 Russia Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 179 Russia Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 180 Russia Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 181 Spain Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 182 Spain Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 183 Spain Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 184 Spain Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 185 Spain Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 186 Spain Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 187 Spain Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 188 Spain Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 189 Spain Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 190 Spain Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 191 Italy Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 192 Italy Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 193 Italy Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 194 Italy Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 195 Italy Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 196 Italy Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 197 Italy Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 198 Italy Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 199 Italy Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 200 Italy Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 201 Rest of Europe Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 202 Rest of Europe Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 203 Rest of Europe Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 204 Rest of Europe Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 205 Rest of Europe Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 206 Rest of Europe Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 207 Rest of Europe Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 208 Rest of Europe Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 209 Rest of Europe Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 210 Rest of Europe Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 211 Asia Pacific Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 213 Asia Pacific Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 214 Asia Pacific Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 215 Asia Pacific Semisynthetic Penicillin Market by Country, 2019 - 2022, USD Million
  • TABLE 216 Asia Pacific Semisynthetic Penicillin Market by Country, 2023 - 2030, USD Million
  • TABLE 217 Asia Pacific Natural Penicillin Market by Country, 2019 - 2022, USD Million
  • TABLE 218 Asia Pacific Natural Penicillin Market by Country, 2023 - 2030, USD Million
  • TABLE 219 Asia Pacific Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 220 Asia Pacific Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 221 Asia Pacific Broad spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 222 Asia Pacific Broad spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 223 Asia Pacific Extended spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 224 Asia Pacific Extended spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 225 Asia Pacific Narrow spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 226 Asia Pacific Narrow spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 227 Asia Pacific Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 228 Asia Pacific Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 229 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 230 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 231 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 232 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 233 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
  • TABLE 234 Asia Pacific Online Providers Market by Country, 2023 - 2030, USD Million
  • TABLE 235 Asia Pacific Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 236 Asia Pacific Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 237 Asia Pacific Parenteral Market by Country, 2019 - 2022, USD Million
  • TABLE 238 Asia Pacific Parenteral Market by Country, 2023 - 2030, USD Million
  • TABLE 239 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 240 Asia Pacific Oral Market by Country, 2023 - 2030, USD Million
  • TABLE 241 Asia Pacific Penicillin Drug Market by Country, 2019 - 2022, USD Million
  • TABLE 242 Asia Pacific Penicillin Drug Market by Country, 2023 - 2030, USD Million
  • TABLE 243 China Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 244 China Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 245 China Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 246 China Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 247 China Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 248 China Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 249 China Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 250 China Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 251 China Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 252 China Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 253 Japan Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 254 Japan Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 255 Japan Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 256 Japan Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 257 Japan Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 258 Japan Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 259 Japan Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 260 Japan Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 261 Japan Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 262 Japan Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 263 India Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 264 India Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 265 India Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 266 India Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 267 India Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 268 India Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 269 India Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 270 India Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 271 India Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 272 India Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 273 South Korea Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 274 South Korea Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 275 South Korea Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 276 South Korea Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 277 South Korea Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 278 South Korea Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 279 South Korea Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 280 South Korea Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 281 South Korea Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 282 South Korea Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 283 Singapore Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 284 Singapore Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 285 Singapore Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 286 Singapore Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 287 Singapore Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 288 Singapore Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 289 Singapore Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 290 Singapore Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 291 Singapore Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 292 Singapore Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 293 Malaysia Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 294 Malaysia Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 295 Malaysia Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 296 Malaysia Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 297 Malaysia Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 298 Malaysia Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 299 Malaysia Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 300 Malaysia Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 301 Malaysia Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 302 Malaysia Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 303 Rest of Asia Pacific Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 304 Rest of Asia Pacific Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 305 Rest of Asia Pacific Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 306 Rest of Asia Pacific Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 307 Rest of Asia Pacific Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 308 Rest of Asia Pacific Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 309 Rest of Asia Pacific Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 310 Rest of Asia Pacific Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 311 Rest of Asia Pacific Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 312 Rest of Asia Pacific Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 313 LAMEA Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 314 LAMEA Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 315 LAMEA Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 316 LAMEA Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 317 LAMEA Semisynthetic Penicillin Market by Country, 2019 - 2022, USD Million
  • TABLE 318 LAMEA Semisynthetic Penicillin Market by Country, 2023 - 2030, USD Million
  • TABLE 319 LAMEA Natural Penicillin Market by Country, 2019 - 2022, USD Million
  • TABLE 320 LAMEA Natural Penicillin Market by Country, 2023 - 2030, USD Million
  • TABLE 321 LAMEA Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 322 LAMEA Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 323 LAMEA Broad spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 324 LAMEA Broad spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 325 LAMEA Extended spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 326 LAMEA Extended spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 327 LAMEA Narrow spectrum Market by Country, 2019 - 2022, USD Million
  • TABLE 328 LAMEA Narrow spectrum Market by Country, 2023 - 2030, USD Million
  • TABLE 329 LAMEA Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 330 LAMEA Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 331 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 332 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 333 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 334 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 335 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
  • TABLE 336 LAMEA Online Providers Market by Country, 2023 - 2030, USD Million
  • TABLE 337 LAMEA Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 338 LAMEA Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 339 LAMEA Parenteral Market by Country, 2019 - 2022, USD Million
  • TABLE 340 LAMEA Parenteral Market by Country, 2023 - 2030, USD Million
  • TABLE 341 LAMEA Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 342 LAMEA Oral Market by Country, 2023 - 2030, USD Million
  • TABLE 343 LAMEA Penicillin Drug Market by Country, 2019 - 2022, USD Million
  • TABLE 344 LAMEA Penicillin Drug Market by Country, 2023 - 2030, USD Million
  • TABLE 345 Brazil Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 346 Brazil Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 347 Brazil Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 348 Brazil Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 349 Brazil Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 350 Brazil Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 351 Brazil Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 352 Brazil Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 353 Brazil Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 354 Brazil Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 355 Argentina Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 356 Argentina Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 357 Argentina Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 358 Argentina Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 359 Argentina Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 360 Argentina Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 361 Argentina Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 362 Argentina Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 363 Argentina Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 364 Argentina Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 365 UAE Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 366 UAE Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 367 UAE Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 368 UAE Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 369 UAE Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 370 UAE Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 371 UAE Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 372 UAE Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 373 UAE Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 374 UAE Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 375 Saudi Arabia Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 376 Saudi Arabia Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 377 Saudi Arabia Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 378 Saudi Arabia Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 379 Saudi Arabia Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 380 Saudi Arabia Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 381 Saudi Arabia Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 382 Saudi Arabia Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 383 Saudi Arabia Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 384 Saudi Arabia Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 385 South Africa Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 386 South Africa Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 387 South Africa Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 388 South Africa Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 389 South Africa Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 390 South Africa Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 391 South Africa Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 392 South Africa Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 393 South Africa Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 394 South Africa Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 395 Nigeria Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 396 Nigeria Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 397 Nigeria Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 398 Nigeria Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 399 Nigeria Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 400 Nigeria Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 401 Nigeria Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 402 Nigeria Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 403 Nigeria Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 404 Nigeria Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 405 Rest of LAMEA Penicillin Drug Market, 2019 - 2022, USD Million
  • TABLE 406 Rest of LAMEA Penicillin Drug Market, 2023 - 2030, USD Million
  • TABLE 407 Rest of LAMEA Penicillin Drug Market by Source, 2019 - 2022, USD Million
  • TABLE 408 Rest of LAMEA Penicillin Drug Market by Source, 2023 - 2030, USD Million
  • TABLE 409 Rest of LAMEA Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
  • TABLE 410 Rest of LAMEA Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
  • TABLE 411 Rest of LAMEA Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 412 Rest of LAMEA Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 413 Rest of LAMEA Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 414 Rest of LAMEA Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
  • TABLE 415 Key Information - Novartis AG
  • TABLE 416 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 417 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 418 Key Information - GlaxoSmithKline PLC
  • TABLE 419 Key Information - Pfizer, Inc.
  • TABLE 420 Key Information - Lupin Limited
  • TABLE 421 Key Information - Abbott Laboratories
  • TABLE 422 Key Information - Cipla Limited
  • TABLE 423 Key Information - Alkem Laboratories Ltd.
  • TABLE 424 Key Information - Takeda Pharmaceutical Company Limited

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Penicillin Drug Market, 2019 - 2030, USD Million
  • FIG 3 Key Factors Impacting Penicillin Drug Market
  • FIG 4 KBV Cardinal Matrix
  • FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
  • FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun - 2023, Mar) Leading Players
  • FIG 7 Porter's Five Forces Analysis - Penicillin Drug Market
  • FIG 8 Global Penicillin Drug Market SHARE by Source, 2022
  • FIG 9 Global Penicillin Drug Market SHARE by Source, 2030
  • FIG 10 Global Penicillin Drug Market by Source, 2019 - 2030, USD Million
  • FIG 11 Global Penicillin Drug Market SHARE by Spectrum of Activity, 2022
  • FIG 12 Global Penicillin Drug Market SHARE by Spectrum of Activity, 2030
  • FIG 13 Global Penicillin Drug Market by Spectrum of Activity, 2019 - 2030, USD Million
  • FIG 14 Global Penicillin Drug Market SHARE by Distribution Channel, 2022
  • FIG 15 Global Penicillin Drug Market SHARE by Distribution Channel, 2030
  • FIG 16 Global Penicillin Drug Market by Distribution Channel, 2019 - 2030, USD Million
  • FIG 17 Global Penicillin Drug Market SHARE by Route of Administration, 2022
  • FIG 18 Global Penicillin Drug Market SHARE by Route of Administration, 2030
  • FIG 19 Global Penicillin Drug Market by Route of Administration, 2019 - 2030, USD Million
  • FIG 20 Global Penicillin Drug Market SHARE by Region, 2022
  • FIG 21 Global Penicillin Drug Market SHARE by Region, 2030
  • FIG 22 Global Penicillin Drug Market by Region, 2019 - 2030, USD Million
  • FIG 23 SWOT Analysis: Novartis AG
  • FIG 24 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
  • FIG 25 SWOT Analysis: Sun Pharmaceutical Industries Ltd.
  • FIG 26 SWOT Analysis: GlaxoSmithKline PLC
  • FIG 27 Recent strategies and developments: Pfizer, Inc.
  • FIG 28 SWOT Analysis: Pfizer, Inc.
  • FIG 29 SWOT Analysis: Lupin Limited
  • FIG 30 SWOT Analysis: Abbott Laboratories
  • FIG 31 SWOT Analysis: Cipla Limited
  • FIG 32 SWOT Analysis: Alkem Laboratories Ltd.
  • FIG 33 SWOT Analysis: Takeda Pharmaceutical Company Limited
目次

The Global Penicillin Drug Market size is expected to reach $10.9 billion by 2030, rising at a market growth of 3.6% CAGR during the forecast period.

Due to factors like the rising prevalence of infectious diseases, better healthcare infrastructure, key market players, and expanding awareness campaigns, North America region is expected to register more than 25% share of the market by 2030. According to Canadian Cancer Statistics, 45% of men and 43% of women in Canada will have cancer at some point in their lives. As the population of Canada ages and grows larger, the prevalence of new cancer cases has been continuously increasing in different cancers like throat, and lungs. Also, the growing elderly and pediatric populations in the region, who are more vulnerable to contracting infectious diseases because of low immunity, are anticipated to support the expansion of market.

The major strategies followed by the market participants are Partnerships as the key developmental strategy in order to keep pace with the changing demands of end users. For instance, In September, 2022, GlaxoSmithKline PLC partnered with Spero Therapeutics, Inc. to use Spero's tebipenem pivoxil hydrobromide antibiotic drug and allow GlaxoSmithKline to offer better treatment options for patients with urinary tract infections. Moreover, In March,2021, Cipla Limited entered a partnership with SIGA Technologies, Inc. to develop solutions for novel antibacterial drugs for countering biothreats.

Based on the Analysis presented in the KBV Cardinal matrix; Pfizer, Inc. is the forerunner in the Market. In January, 2022, Pfizer, Inc. came into partnership with Becton, Dickinson, and Company to develop solutions for the correct use of antimicrobial drugs. Companies such as GlaxoSmithKline PLC (GSK), Novartis AG, Abbott Laboratories are some of the key innovators in the Market.

Market Growth Factors

Increased Incidence of Bacterial Illness

Diseases caused by bacteria significantly impact the public's health. Anybody may acquire the disease, which can be brought on either by the organism itself or by the body's reaction to its existence. Humans can contract bacteria via food, water, the air, or living things. The medication destroys the enzymes that help bacteria form their cell walls. For different infections, different types of penicillin are utilized. Amoxicillin, ampicillin, Augmentin, penicillin G, and penicillin V are a few varieties of penicillin. In consideration to the above-mentioned elements, it is projected that the expanding bacterial infection will boost the expansion of the market.

Increasing Demand for Efficient and Modern Antibiotics

Developing and bringing new antibiotics to market is a difficult task. Still, it must be accomplished if the person is better protected against the rising threat of drug-resistant illnesses. Modern medicine has revolutionized since the first antibiotic, penicillin, was discovered. Bacteria will ultimately acquire resistance to the new medications. Also, they require advancements in creating diagnostics, vaccinations, and better prevention, control, and monitoring to stay ahead of the never-ending battle against superbugs. According to the WHO, 40 to 50 antibiotics are in clinical development. As a result, this market will grow in the next years due to the increasing demand for antibiotics.

Market Restraining Factors

Rise In Multi-Drug Resistant (MDR) Infections

One of the biggest issues affecting the healthcare system is antibiotic resistance, which presents a significant risk to public health. These strains were initially isolated to the hospital environment but are now prevalent. The causes identified as causing the spread of antibiotic resistance include globalization, aquaculture, the use of several broad-spectrum drugs, excessive use of antibiotics in animal husbandry, and a lack of proper antimicrobial stewardship. Given the rise in antibiotic-resistant organisms, there must be fewer antimicrobial medicines available to treat diseases.

Source Outlook

On the basis of source, the market is segmented into natural penicillin, and semisynthetic penicillin. The natural penicillin acquired a substantial revenue share in the market in 2022. Natural penicillins are efficient against both gram-positive and gram-negative bacteria, including Borrelia, streptococci, meningococci, staphylococci, Treponema, and Leptospira. Penicillin V is only for oral use, and penicillin G is for parenteral use. Except for Bacteroides fragilis, these medications are most often used to diagnose diseases brought on by gram-positive bacteria, including anaerobes.

Spectrum of Activity Outlook

By spectrum of activity, the market is categorised into narrow spectrum, broad spectrum, and extended spectrum. In 2022, the broad-spectrum segment witnessed the largest revenue share in the market. Infections of the throat, ear, nasal sinuses, respiratory tract (such as pneumonia), urinary tract, skin and soft tissue, and typhoid fever can all be treated with broad-spectrum penicillins, a class of antibiotics related to penicillin. Ampicillin and its esters, which include bacapicillin, pivampicillin, and talampicillin, as well as amoxycillin, co-amoxiclav, and mezlocillin are the major broad-spectrum penicillins.

Distribution Channel Outlook

On the basis of distribution channel, the market is fragmented into hospital pharmacies, drug stores & retail pharmacies, and online providers. The online providers segment projected a prominent revenue share in the market in 2022. Penicillin drugs are available through several online vendors, enabling consumers to find certain brands, doses, and formulations that suit their unique needs. Additionally, users can shop online at any time because of the platforms' 24/7 availability. These factors will lead the growth in this segment.

Route of Administration Outlook

Based on route of administration, the market is classified into oral, and parenteral. In 2022, the parenteral segment held the highest revenue share in the market. Due to the increased use of penicillin injections for the treatment of serious bacterial infections and the rise in syphilis prevalence, for which penicillin G injections are the primary treatment. Sometimes, parenteral administration is favored over other drug delivery methods, such as cardiac arrest and anaphylactic shock emergencies.

Regional Outlook

Region wise, the market is analysed into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region led the market by generating highest revenue share. The growth can be related to the region's rising incidence of infectious diseases and the rising demand for penicillin drugs. With the expanding populations of nations like China and India, the Asia-Pacific region is one of the greatest markets for antibiotics, including the penicillin drugs. Furthermore, the Asia-Pacific market has expanded significantly due to factors like rising healthcare costs, improved healthcare infrastructure, rising antibiotic usage knowledge, and the presence of major pharmaceutical companies in the region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Novartis AG, Lupin Limited, Abbott Laboratories, Cipla Limited, Takeda Pharmaceutical Company Limited, Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd.

Recent Strategies Deployed in Penicillin Drug Market

Partnerships, Collaborations & Agreements:

Mar-2023: GlaxoSmithKline PLC signed a partnership with SCYNEXIS, Inc, a pharmaceuticals company based in the United States, to use SCYNEXIS' Brexafemme tablets. The addition of Brexafemme would strengthen GlaxoSmithKline's antibiotic portfolio.

Sep-2022: GlaxoSmithKline PLC partnered with Spero Therapeutics, Inc., a US-based biotech company, to use Spero's tebipenem pivoxil hydrobromide antibiotic drug. The partnership would allow GlaxoSmithKline to offer better treatment options for patients with urinary tract infections.

Apr-2022: Novartis AG announced a partnership with Sandoz, a Swiss pharmaceutical company, to develop solutions against antimicrobial resistance. The combined expertise of the two companies would pave the way for countering the threat of antimicrobial resistance (AMR).

Jan-2022: Pfizer, Inc. came into partnership with Becton, Dickinson, and Company, a biotech company based in the United States, to develop solutions for the correct use of antimicrobial drugs. The partnership would enable the customers of the two companies to benefit from better diagnosis and treatment.

Mar-2021: Cipla Limited entered a partnership with SIGA Technologies, Inc., a pharmaceutical company, to develop solutions for novel antibacterial drugs for countering biothreats. The combined expertise of the two companies would pave the way for biothreat treatment in the US market.

Mergers & Acquisition:

Jan-2023: Sun Pharmaceutical Industries Ltd. announced the acquisition of three brands namely, Disperzyme-CD, Disperzyme, and Phlogam from Aksigen Hospital Care, an Indian-based pharmaceutical company. The acquisition enhances the company's anti-inflammatory portfolio.

Dec-2022: Takeda Pharmaceutical Company Limited took over autoimmune disease treatment drugs from Nimbus Therapeutics, a therapeutics company based in the US. The acquisition builds up Takeda's therapeutic business.

Mar-2022: Pfizer, Inc. announced the acquisition of Arena Pharmaceuticals, an immuno-inflammatory disease specialist. The acquisition builds up the company's capability for immuno-inflammatory disease treatment.

Oct-2021: Novartis AG acquired the cephalosporin antibiotics division from GSK, a British biopharma company. The acquisition strengthens Novartis' foothold in the antibiotics market.

Product Launches and Product Expansions:

Jan-2023: Alkem Laboratories Ltd. introduced Zidavi, a novel anti-infective drug. The drug is made up of a mixture of avibactam and ceftazidime and has the main application in Urinary Tract Infections treatment.

Trials and Approvals:

Apr-2023: Pfizer, Inc. received approval from U.S. Food and Drug Administration for its PREVNAR 20. The PREVNAR 20 is a vaccine-based treatment for children, under 17 years of age, with pneumococcal disease.

Scope of the Study

Market Segments covered in the Report:

By Source

  • Semisynthetic Penicillin
  • Natural Penicillin

By Spectrum of Activity

  • Broad spectrum
  • Extended spectrum
  • Narrow spectrum

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Route of Administration

  • Parenteral
  • Oral

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Novartis AG
  • Lupin Limited
  • Abbott Laboratories
  • Cipla Limited
  • Takeda Pharmaceutical Company Limited
  • Alkem Laboratories Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Penicillin Drug Market, by Source
    • 1.4.2 Global Penicillin Drug Market, by Spectrum of Activity
    • 1.4.3 Global Penicillin Drug Market, by Distribution Channel
    • 1.4.4 Global Penicillin Drug Market, by Route of Administration
    • 1.4.5 Global Penicillin Drug Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
    • 4.2.4 Trials and Approvals
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
    • 4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun - 2023, Mar) Leading Players
  • 4.4 Porter Five Forces Analysis

Chapter 5. Global Penicillin Drug Market by Source

  • 5.1 Global Semisynthetic Penicillin Market by Region
  • 5.2 Global Natural Penicillin Market by Region

Chapter 6. Global Penicillin Drug Market by Spectrum of Activity

  • 6.1 Global Broad spectrum Market by Region
  • 6.2 Global Extended spectrum Market by Region
  • 6.3 Global Narrow spectrum Market by Region

Chapter 7. Global Penicillin Drug Market by Distribution Channel

  • 7.1 Global Drug Stores & Retail Pharmacies Market by Region
  • 7.2 Global Hospital Pharmacies Market by Region
  • 7.3 Global Online Providers Market by Region

Chapter 8. Global Penicillin Drug Market by Route of Administration

  • 8.1 Global Parenteral Market by Region
  • 8.2 Global Oral Market by Region

Chapter 9. Global Penicillin Drug Market by Region

  • 9.1 North America Penicillin Drug Market
    • 9.1.1 North America Penicillin Drug Market by Source
      • 9.1.1.1 North America Semisynthetic Penicillin Market by Country
      • 9.1.1.2 North America Natural Penicillin Market by Country
    • 9.1.2 North America Penicillin Drug Market by Spectrum of Activity
      • 9.1.2.1 North America Broad spectrum Market by Country
      • 9.1.2.2 North America Extended spectrum Market by Country
      • 9.1.2.3 North America Narrow spectrum Market by Country
    • 9.1.3 North America Penicillin Drug Market by Distribution Channel
      • 9.1.3.1 North America Drug Stores & Retail Pharmacies Market by Country
      • 9.1.3.2 North America Hospital Pharmacies Market by Country
      • 9.1.3.3 North America Online Providers Market by Country
    • 9.1.4 North America Penicillin Drug Market by Route of Administration
      • 9.1.4.1 North America Parenteral Market by Country
      • 9.1.4.2 North America Oral Market by Country
    • 9.1.5 North America Penicillin Drug Market by Country
      • 9.1.5.1 US Penicillin Drug Market
        • 9.1.5.1.1 US Penicillin Drug Market by Source
        • 9.1.5.1.2 US Penicillin Drug Market by Spectrum of Activity
        • 9.1.5.1.3 US Penicillin Drug Market by Distribution Channel
        • 9.1.5.1.4 US Penicillin Drug Market by Route of Administration
      • 9.1.5.2 Canada Penicillin Drug Market
        • 9.1.5.2.1 Canada Penicillin Drug Market by Source
        • 9.1.5.2.2 Canada Penicillin Drug Market by Spectrum of Activity
        • 9.1.5.2.3 Canada Penicillin Drug Market by Distribution Channel
        • 9.1.5.2.4 Canada Penicillin Drug Market by Route of Administration
      • 9.1.5.3 Mexico Penicillin Drug Market
        • 9.1.5.3.1 Mexico Penicillin Drug Market by Source
        • 9.1.5.3.2 Mexico Penicillin Drug Market by Spectrum of Activity
        • 9.1.5.3.3 Mexico Penicillin Drug Market by Distribution Channel
        • 9.1.5.3.4 Mexico Penicillin Drug Market by Route of Administration
      • 9.1.5.4 Rest of North America Penicillin Drug Market
        • 9.1.5.4.1 Rest of North America Penicillin Drug Market by Source
        • 9.1.5.4.2 Rest of North America Penicillin Drug Market by Spectrum of Activity
        • 9.1.5.4.3 Rest of North America Penicillin Drug Market by Distribution Channel
        • 9.1.5.4.4 Rest of North America Penicillin Drug Market by Route of Administration
  • 9.2 Europe Penicillin Drug Market
    • 9.2.1 Europe Penicillin Drug Market by Source
      • 9.2.1.1 Europe Semisynthetic Penicillin Market by Country
      • 9.2.1.2 Europe Natural Penicillin Market by Country
    • 9.2.2 Europe Penicillin Drug Market by Spectrum of Activity
      • 9.2.2.1 Europe Broad spectrum Market by Country
      • 9.2.2.2 Europe Extended spectrum Market by Country
      • 9.2.2.3 Europe Narrow spectrum Market by Country
    • 9.2.3 Europe Penicillin Drug Market by Distribution Channel
      • 9.2.3.1 Europe Drug Stores & Retail Pharmacies Market by Country
      • 9.2.3.2 Europe Hospital Pharmacies Market by Country
      • 9.2.3.3 Europe Online Providers Market by Country
    • 9.2.4 Europe Penicillin Drug Market by Route of Administration
      • 9.2.4.1 Europe Parenteral Market by Country
      • 9.2.4.2 Europe Oral Market by Country
    • 9.2.5 Europe Penicillin Drug Market by Country
      • 9.2.5.1 Germany Penicillin Drug Market
        • 9.2.5.1.1 Germany Penicillin Drug Market by Source
        • 9.2.5.1.2 Germany Penicillin Drug Market by Spectrum of Activity
        • 9.2.5.1.3 Germany Penicillin Drug Market by Distribution Channel
        • 9.2.5.1.4 Germany Penicillin Drug Market by Route of Administration
      • 9.2.5.2 UK Penicillin Drug Market
        • 9.2.5.2.1 UK Penicillin Drug Market by Source
        • 9.2.5.2.2 UK Penicillin Drug Market by Spectrum of Activity
        • 9.2.5.2.3 UK Penicillin Drug Market by Distribution Channel
        • 9.2.5.2.4 UK Penicillin Drug Market by Route of Administration
      • 9.2.5.3 France Penicillin Drug Market
        • 9.2.5.3.1 France Penicillin Drug Market by Source
        • 9.2.5.3.2 France Penicillin Drug Market by Spectrum of Activity
        • 9.2.5.3.3 France Penicillin Drug Market by Distribution Channel
        • 9.2.5.3.4 France Penicillin Drug Market by Route of Administration
      • 9.2.5.4 Russia Penicillin Drug Market
        • 9.2.5.4.1 Russia Penicillin Drug Market by Source
        • 9.2.5.4.2 Russia Penicillin Drug Market by Spectrum of Activity
        • 9.2.5.4.3 Russia Penicillin Drug Market by Distribution Channel
        • 9.2.5.4.4 Russia Penicillin Drug Market by Route of Administration
      • 9.2.5.5 Spain Penicillin Drug Market
        • 9.2.5.5.1 Spain Penicillin Drug Market by Source
        • 9.2.5.5.2 Spain Penicillin Drug Market by Spectrum of Activity
        • 9.2.5.5.3 Spain Penicillin Drug Market by Distribution Channel
        • 9.2.5.5.4 Spain Penicillin Drug Market by Route of Administration
      • 9.2.5.6 Italy Penicillin Drug Market
        • 9.2.5.6.1 Italy Penicillin Drug Market by Source
        • 9.2.5.6.2 Italy Penicillin Drug Market by Spectrum of Activity
        • 9.2.5.6.3 Italy Penicillin Drug Market by Distribution Channel
        • 9.2.5.6.4 Italy Penicillin Drug Market by Route of Administration
      • 9.2.5.7 Rest of Europe Penicillin Drug Market
        • 9.2.5.7.1 Rest of Europe Penicillin Drug Market by Source
        • 9.2.5.7.2 Rest of Europe Penicillin Drug Market by Spectrum of Activity
        • 9.2.5.7.3 Rest of Europe Penicillin Drug Market by Distribution Channel
        • 9.2.5.7.4 Rest of Europe Penicillin Drug Market by Route of Administration
  • 9.3 Asia Pacific Penicillin Drug Market
    • 9.3.1 Asia Pacific Penicillin Drug Market by Source
      • 9.3.1.1 Asia Pacific Semisynthetic Penicillin Market by Country
      • 9.3.1.2 Asia Pacific Natural Penicillin Market by Country
    • 9.3.2 Asia Pacific Penicillin Drug Market by Spectrum of Activity
      • 9.3.2.1 Asia Pacific Broad spectrum Market by Country
      • 9.3.2.2 Asia Pacific Extended spectrum Market by Country
      • 9.3.2.3 Asia Pacific Narrow spectrum Market by Country
    • 9.3.3 Asia Pacific Penicillin Drug Market by Distribution Channel
      • 9.3.3.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
      • 9.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
      • 9.3.3.3 Asia Pacific Online Providers Market by Country
    • 9.3.4 Asia Pacific Penicillin Drug Market by Route of Administration
      • 9.3.4.1 Asia Pacific Parenteral Market by Country
      • 9.3.4.2 Asia Pacific Oral Market by Country
    • 9.3.5 Asia Pacific Penicillin Drug Market by Country
      • 9.3.5.1 China Penicillin Drug Market
        • 9.3.5.1.1 China Penicillin Drug Market by Source
        • 9.3.5.1.2 China Penicillin Drug Market by Spectrum of Activity
        • 9.3.5.1.3 China Penicillin Drug Market by Distribution Channel
        • 9.3.5.1.4 China Penicillin Drug Market by Route of Administration
      • 9.3.5.2 Japan Penicillin Drug Market
        • 9.3.5.2.1 Japan Penicillin Drug Market by Source
        • 9.3.5.2.2 Japan Penicillin Drug Market by Spectrum of Activity
        • 9.3.5.2.3 Japan Penicillin Drug Market by Distribution Channel
        • 9.3.5.2.4 Japan Penicillin Drug Market by Route of Administration
      • 9.3.5.3 India Penicillin Drug Market
        • 9.3.5.3.1 India Penicillin Drug Market by Source
        • 9.3.5.3.2 India Penicillin Drug Market by Spectrum of Activity
        • 9.3.5.3.3 India Penicillin Drug Market by Distribution Channel
        • 9.3.5.3.4 India Penicillin Drug Market by Route of Administration
      • 9.3.5.4 South Korea Penicillin Drug Market
        • 9.3.5.4.1 South Korea Penicillin Drug Market by Source
        • 9.3.5.4.2 South Korea Penicillin Drug Market by Spectrum of Activity
        • 9.3.5.4.3 South Korea Penicillin Drug Market by Distribution Channel
        • 9.3.5.4.4 South Korea Penicillin Drug Market by Route of Administration
      • 9.3.5.5 Singapore Penicillin Drug Market
        • 9.3.5.5.1 Singapore Penicillin Drug Market by Source
        • 9.3.5.5.2 Singapore Penicillin Drug Market by Spectrum of Activity
        • 9.3.5.5.3 Singapore Penicillin Drug Market by Distribution Channel
        • 9.3.5.5.4 Singapore Penicillin Drug Market by Route of Administration
      • 9.3.5.6 Malaysia Penicillin Drug Market
        • 9.3.5.6.1 Malaysia Penicillin Drug Market by Source
        • 9.3.5.6.2 Malaysia Penicillin Drug Market by Spectrum of Activity
        • 9.3.5.6.3 Malaysia Penicillin Drug Market by Distribution Channel
        • 9.3.5.6.4 Malaysia Penicillin Drug Market by Route of Administration
      • 9.3.5.7 Rest of Asia Pacific Penicillin Drug Market
        • 9.3.5.7.1 Rest of Asia Pacific Penicillin Drug Market by Source
        • 9.3.5.7.2 Rest of Asia Pacific Penicillin Drug Market by Spectrum of Activity
        • 9.3.5.7.3 Rest of Asia Pacific Penicillin Drug Market by Distribution Channel
        • 9.3.5.7.4 Rest of Asia Pacific Penicillin Drug Market by Route of Administration
  • 9.4 LAMEA Penicillin Drug Market
    • 9.4.1 LAMEA Penicillin Drug Market by Source
      • 9.4.1.1 LAMEA Semisynthetic Penicillin Market by Country
      • 9.4.1.2 LAMEA Natural Penicillin Market by Country
    • 9.4.2 LAMEA Penicillin Drug Market by Spectrum of Activity
      • 9.4.2.1 LAMEA Broad spectrum Market by Country
      • 9.4.2.2 LAMEA Extended spectrum Market by Country
      • 9.4.2.3 LAMEA Narrow spectrum Market by Country
    • 9.4.3 LAMEA Penicillin Drug Market by Distribution Channel
      • 9.4.3.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
      • 9.4.3.2 LAMEA Hospital Pharmacies Market by Country
      • 9.4.3.3 LAMEA Online Providers Market by Country
    • 9.4.4 LAMEA Penicillin Drug Market by Route of Administration
      • 9.4.4.1 LAMEA Parenteral Market by Country
      • 9.4.4.2 LAMEA Oral Market by Country
    • 9.4.5 LAMEA Penicillin Drug Market by Country
      • 9.4.5.1 Brazil Penicillin Drug Market
        • 9.4.5.1.1 Brazil Penicillin Drug Market by Source
        • 9.4.5.1.2 Brazil Penicillin Drug Market by Spectrum of Activity
        • 9.4.5.1.3 Brazil Penicillin Drug Market by Distribution Channel
        • 9.4.5.1.4 Brazil Penicillin Drug Market by Route of Administration
      • 9.4.5.2 Argentina Penicillin Drug Market
        • 9.4.5.2.1 Argentina Penicillin Drug Market by Source
        • 9.4.5.2.2 Argentina Penicillin Drug Market by Spectrum of Activity
        • 9.4.5.2.3 Argentina Penicillin Drug Market by Distribution Channel
        • 9.4.5.2.4 Argentina Penicillin Drug Market by Route of Administration
      • 9.4.5.3 UAE Penicillin Drug Market
        • 9.4.5.3.1 UAE Penicillin Drug Market by Source
        • 9.4.5.3.2 UAE Penicillin Drug Market by Spectrum of Activity
        • 9.4.5.3.3 UAE Penicillin Drug Market by Distribution Channel
        • 9.4.5.3.4 UAE Penicillin Drug Market by Route of Administration
      • 9.4.5.4 Saudi Arabia Penicillin Drug Market
        • 9.4.5.4.1 Saudi Arabia Penicillin Drug Market by Source
        • 9.4.5.4.2 Saudi Arabia Penicillin Drug Market by Spectrum of Activity
        • 9.4.5.4.3 Saudi Arabia Penicillin Drug Market by Distribution Channel
        • 9.4.5.4.4 Saudi Arabia Penicillin Drug Market by Route of Administration
      • 9.4.5.5 South Africa Penicillin Drug Market
        • 9.4.5.5.1 South Africa Penicillin Drug Market by Source
        • 9.4.5.5.2 South Africa Penicillin Drug Market by Spectrum of Activity
        • 9.4.5.5.3 South Africa Penicillin Drug Market by Distribution Channel
        • 9.4.5.5.4 South Africa Penicillin Drug Market by Route of Administration
      • 9.4.5.6 Nigeria Penicillin Drug Market
        • 9.4.5.6.1 Nigeria Penicillin Drug Market by Source
        • 9.4.5.6.2 Nigeria Penicillin Drug Market by Spectrum of Activity
        • 9.4.5.6.3 Nigeria Penicillin Drug Market by Distribution Channel
        • 9.4.5.6.4 Nigeria Penicillin Drug Market by Route of Administration
      • 9.4.5.7 Rest of LAMEA Penicillin Drug Market
        • 9.4.5.7.1 Rest of LAMEA Penicillin Drug Market by Source
        • 9.4.5.7.2 Rest of LAMEA Penicillin Drug Market by Spectrum of Activity
        • 9.4.5.7.3 Rest of LAMEA Penicillin Drug Market by Distribution Channel
        • 9.4.5.7.4 Rest of LAMEA Penicillin Drug Market by Route of Administration

Chapter 10. Company Profiles

  • 10.1 Novartis AG
    • 10.1.1 Company Overview
    • 10.1.2 Financial Analysis
    • 10.1.3 Segmental and Regional Analysis
    • 10.1.4 Research & Development Expense
    • 10.1.5 Recent strategies and developments:
      • 10.1.5.1 Partnerships, Collaborations, and Agreements:
      • 10.1.5.2 Acquisition and Mergers:
    • 10.1.6 SWOT Analysis
  • 10.2 Teva Pharmaceutical Industries Ltd.
    • 10.2.1 Company Overview
    • 10.2.2 Financial Analysis
    • 10.2.3 Regional Analysis
    • 10.2.4 Research & Development Expenses
    • 10.2.5 SWOT Analysis
  • 10.3 Sun Pharmaceutical Industries Ltd.
    • 10.3.1 Company Overview
    • 10.3.2 Financial Analysis
    • 10.3.3 Regional Analysis
    • 10.3.4 Research & Development Expenses
    • 10.3.5 Recent strategies and developments:
      • 10.3.5.1 Acquisition and Mergers:
    • 10.3.6 SWOT Analysis
  • 10.4 GlaxoSmithKline PLC (GSK)
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Regional Analysis
    • 10.4.4 Research & Development Expense
    • 10.4.5 Recent strategies and developments:
      • 10.4.5.1 Partnerships, Collaborations, and Agreements:
    • 10.4.6 SWOT Analysis
  • 10.5 Pfizer, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Financial Analysis
    • 10.5.3 Regional & Segmental Analysis
    • 10.5.4 Research & Development Expense
    • 10.5.5 Recent strategies and developments:
      • 10.5.5.1 Partnerships, Collaborations, and Agreements:
      • 10.5.5.2 Acquisition and Mergers:
      • 10.5.5.3 Trials and Approvals:
    • 10.5.6 SWOT Analysis
  • 10.6 Lupin Limited
    • 10.6.1 Company Overview
    • 10.6.2 Financial Analysis
    • 10.6.3 Recent strategies and developments:
      • 10.6.3.1 Partnerships, Collaborations, and Agreements:
    • 10.6.4 SWOT Analysis
  • 10.7 Abbott Laboratories
    • 10.7.1 Company Overview
    • 10.7.2 Financial Analysis
    • 10.7.3 Segmental and Regional Analysis
    • 10.7.4 Research & Development Expense
    • 10.7.5 SWOT Analysis
  • 10.8 Cipla Limited
    • 10.8.1 Company Overview
    • 10.8.2 Financial Analysis
    • 10.8.3 Regional Analysis
    • 10.8.4 Research & Development Expense
    • 10.8.5 Recent strategies and developments:
      • 10.8.5.1 Partnerships, Collaborations, and Agreements:
      • 10.8.5.2 Acquisition and Mergers:
    • 10.8.6 SWOT Analysis
  • 10.9 Alkem Laboratories Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Financial Analysis
    • 10.9.3 Regional Analysis
    • 10.9.4 Research & Development Expenses
    • 10.9.5 Recent strategies and developments:
      • 10.9.5.1 Product Launches and Product Expansions:
    • 10.9.6 SWOT Analysis
  • 10.10. Takeda Pharmaceutical Company Limited
    • 10.10.1 Company Overview
    • 10.10.2 Financial Analysis
    • 10.10.3 Regional Analysis
    • 10.10.4 Research & Development Expense
    • 10.10.5 Recent strategies and developments:
      • 10.10.5.1 Acquisition and Mergers:
    • 10.10.6 SWOT Analysis

Chapter 11. Winning Imperatives for Penicillin Drug Market